| Name | Mcl1-IN-14 |
|---|
| Description | Mcl1-IN-14 (compound C3), a proteolysis targeting chimera (PROTAC), is a potently and selectively Mcl-1 inhibitor with an IC50 of 0.78 μM. Mcl1-IN-14 induces the ubiquitination and proteasomal degradation of Mcl-1 by introducing the E3 ligase cereblon (CRBN)-binding ligand pomalidomide to Mcl-1 inhibitor S1-6 with μM-range affinity[1]. |
|---|---|
| Related Catalog | |
| Target |
Mcl-1:0.78 μM (IC50) |
| References |
| Molecular Formula | C45H45BrN6O8S |
|---|---|
| Molecular Weight | 909.84 |
| Storage condition | 2-8°C |